{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:52:38Z","timestamp":1771879958514,"version":"3.50.1"},"reference-count":64,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0454","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:27:14Z","timestamp":1525253234000},"source":"Crossref","is-referenced-by-count":8,"title":["Outpatient Antibiotic Prescription"],"prefix":"10.3238","author":[{"given":"J\u00f6rg","family":"B\u00e4tzing-Feigenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Hering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"10.3238\/arztebl.2016.0454_ref1","doi-asserted-by":"crossref","unstructured":"Austin DJ, Kristinsson KG, Anderson RM: The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152\u20136","DOI":"10.1073\/pnas.96.3.1152"},{"key":"10.3238\/arztebl.2016.0454_ref2","doi-asserted-by":"crossref","unstructured":"Bronzwaer SL, Cars O, Buchholz U, et al.: European Antimicrobial Resistance Surveillance System\u2014a European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278\u201382","DOI":"10.3201\/eid0803.010192"},{"key":"10.3238\/arztebl.2016.0454_ref3","doi-asserted-by":"crossref","unstructured":"Goossens H, Ferech M, van der Stichele R, et al.: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579\u201387","DOI":"10.1016\/S0140-6736(05)17907-0"},{"key":"10.3238\/arztebl.2016.0454_ref4","unstructured":"Bundesministerium f\u00fcr Gesundheit (BMG), Bundesministerium f\u00fcr Ern\u00e4hrung, Landwirtschaft und Verbraucherschutz (BMELV), Bundesministerium f\u00fcr Bildung und Forschung (BMBF): DART \u2013 Deutsche Antibiotika-Resistenzstrategie. Berlin 2011. http:\/\/mobile.bundesgesundheitsministerium.de\/fileadmin\/dateien\/Publikationen\/Gesundheit\/Broschueren\/Deutsche_Antibiotika_Resistenzstrategie_DART_110331.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref5","unstructured":"Bundesministerium f\u00fcr Gesundheit (BMG), Bundesministerium f\u00fcr Ern\u00e4hrung und Landwirtschaft BMEL), Bundesministerium f\u00fcr Bildung und Forschung (BMBF): DART 2020 \u2013 Antibiotika-Resistenzen bek\u00e4mpfen zum Wohl von Mensch und Tier. Berlin 2015. www.bundesgesundheitsministerium.de\/fileadmin\/dateien\/Publikationen\/Ministerium\/Broschueren\/BMG_DART_2020_Bericht_dt.pdf (last accessed on 22 December 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref6","doi-asserted-by":"crossref","unstructured":"Behnke M, Hansen S, Leistner R, et al.: Nosocomial infection and antibiotic use: a second national prevalence study in Germany. Dtsch Arztebl Int 2013; 110: 627\u201333","DOI":"10.3238\/arztebl.2013.0627"},{"key":"10.3238\/arztebl.2016.0454_ref7","doi-asserted-by":"crossref","unstructured":"Gastmeier P, Weitzel-Kage D, Behnke M, et al.: Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents 2009; 33 (Suppl 1): S19\u201323","DOI":"10.1016\/S0924-8579(09)70011-1"},{"key":"10.3238\/arztebl.2016.0454_ref8","doi-asserted-by":"crossref","unstructured":"L\u00fcbbert C, John E, von M\u00fcller L: Clostridium difficile infection\u2014guideline-based diagnosis and treatment. Dtsch Arztebl Int 2014; 111: 723\u201331","DOI":"10.3238\/arztebl.2014.0723"},{"key":"10.3238\/arztebl.2016.0454_ref9","doi-asserted-by":"crossref","unstructured":"Garg S, Mirza YR, Girotra M, et al.: Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection. Dig Dis Sci 2013; 58: 3407\u201312","DOI":"10.1007\/s10620-013-2848-x"},{"key":"10.3238\/arztebl.2016.0454_ref10","doi-asserted-by":"crossref","unstructured":"de With K, Schr\u00f6der H, Meyer E, et al.: Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr 2004; 129: 1987\u201392","DOI":"10.1055\/s-2004-831838"},{"key":"10.3238\/arztebl.2016.0454_ref11","doi-asserted-by":"crossref","unstructured":"Kern WV, de With K, Nink K, et al.: Regional variation in outpatient antibiotic prescribing in Germany. Infection 2006; 34: 269\u201373","DOI":"10.1007\/s15010-006-6618-y"},{"key":"10.3238\/arztebl.2016.0454_ref12","doi-asserted-by":"crossref","unstructured":"Koller D, Hoffmann F, Maier W, et al.: Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany. Infection 2013; 41: 121\u20137","DOI":"10.1007\/s15010-012-0302-1"},{"key":"10.3238\/arztebl.2016.0454_ref13","doi-asserted-by":"crossref","unstructured":"Augustin J, Mangiapane S, Kern WV: A regional analysis of outpatient antibiotic prescribing in Germany in 2010. Eur J Public Health 2015; 25: 397\u20139","DOI":"10.1093\/eurpub\/ckv050"},{"key":"10.3238\/arztebl.2016.0454_ref14","doi-asserted-by":"crossref","unstructured":"Gallini A, Taboulet F, Bourrel R: Regional variations in quinolone use in France and associated factors. Eur J Clin Microbiol Infect Dis 2012; 31: 2911\u20138","DOI":"10.1007\/s10096-012-1640-8"},{"key":"10.3238\/arztebl.2016.0454_ref15","doi-asserted-by":"crossref","unstructured":"van Eldere J, Mera RM, Miller LA, et al.: Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location. Antimicrob Agents Chemother 2007; 51: 3491\u20137","DOI":"10.1128\/AAC.01581-06"},{"key":"10.3238\/arztebl.2016.0454_ref16","doi-asserted-by":"crossref","unstructured":"Achermann R, Suter K, Kronenberg A, et al.: Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests. Clin Microbiol Infect 2011; 17: 855\u201361 CrossRef","DOI":"10.1111\/j.1469-0691.2010.03348.x"},{"key":"10.3238\/arztebl.2016.0454_ref17","doi-asserted-by":"crossref","unstructured":"Clavenna A, Berti A, Gualandi L, et al.: Drug utilisation profile in the Italian paediatric population. Eur J Pediatr 2009; 168: 173\u201380","DOI":"10.1007\/s00431-008-0725-y"},{"key":"10.3238\/arztebl.2016.0454_ref18","unstructured":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen: Bedarfsgerechte Versorgung \u2013 Perspektiven f\u00fcr l\u00e4ndliche Regionen und ausgew\u00e4hlte Leistungsbereiche. Berlin 2014. www.svr-gesundheit.de\/fileadmin\/user_upload\/Gutachten\/2014\/SVR-Gutachten_2014_Langfassung.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref19","doi-asserted-by":"crossref","unstructured":"Kern WV, de With K: Rationale Antibiotikaverordnung \u2013 mehr Herausforderungen als Erfolge. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012; 55: 1418\u201326","DOI":"10.1007\/s00103-012-1557-5"},{"key":"10.3238\/arztebl.2016.0454_ref20","doi-asserted-by":"crossref","unstructured":"H\u00f6ffken G, Lorenz J, Kern WV, et al.: Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie \u2013 Update 2009. Pneumologie 2009; 63: e1\u201368","DOI":"10.1055\/s-0029-1215037"},{"key":"10.3238\/arztebl.2016.0454_ref21","doi-asserted-by":"crossref","unstructured":"Woodhead M, Blasi F, Ewig S, et al.: Guidelines for the management of adult lower respiratory tract infections\u2014full version. Clin Microbiol Infect 2011; 17 (Suppl 6): E1\u201359","DOI":"10.1111\/j.1469-0691.2011.03672.x"},{"key":"10.3238\/arztebl.2016.0454_ref22","doi-asserted-by":"crossref","unstructured":"Macy E: Penicillin allergy: optimizing diagnostic protocols, public health implications, and future research needs. Curr Opin Allergy Clin Immunol 2015; 15: 308\u201313","DOI":"10.1097\/ACI.0000000000000173"},{"key":"10.3238\/arztebl.2016.0454_ref23","doi-asserted-by":"crossref","unstructured":"Finn AL, Straughn A, Meyer M, et al.: Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos 1987; 8: 519\u201326","DOI":"10.1002\/bdd.2510080604"},{"key":"10.3238\/arztebl.2016.0454_ref24","doi-asserted-by":"crossref","unstructured":"S\u00f8es L, M\u00f8lbak K, Str\u00f8baek S, et al.: The emergence of Clostridium difficile PCR ribotype 027 in Denmark\u2014a possible link with the increased consumption of fluoroquinolones and cephalosporins? Euro Surveill 2009; 14: 1917.","DOI":"10.2807\/ese.14.15.19176-en"},{"key":"10.3238\/arztebl.2016.0454_ref25","doi-asserted-by":"crossref","unstructured":"Hernandez-Santiago V, Marwick CA, Patton A, et al.: Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use. J Antimicrob Chemother 2015; 70: 2397\u2013404","DOI":"10.1093\/jac\/dkv095"},{"key":"10.3238\/arztebl.2016.0454_ref26","doi-asserted-by":"crossref","unstructured":"Deshpande A, Pasupuleti V, Thota P, et al.: Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68: 1951\u201361","DOI":"10.1093\/jac\/dkt129"},{"key":"10.3238\/arztebl.2016.0454_ref27","doi-asserted-by":"crossref","unstructured":"Brown KA, Khanafer N, Daneman N, et al.: Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 2013; 57: 2326\u20133","DOI":"10.1128\/AAC.02176-12"},{"key":"10.3238\/arztebl.2016.0454_ref28","doi-asserted-by":"crossref","unstructured":"Hammerum AM, Larsen J, Andersen VD, et al.: Characterization of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins. J Antimicrob Chemother 2014; 69: 2650\u20137","DOI":"10.1093\/jac\/dku180"},{"key":"10.3238\/arztebl.2016.0454_ref29","doi-asserted-by":"crossref","unstructured":"Knudsen JD, Andersen SE: A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital. PLoS One 2014; 9: e86457","DOI":"10.1371\/journal.pone.0086457"},{"key":"10.3238\/arztebl.2016.0454_ref30","doi-asserted-by":"crossref","unstructured":"Han JH, Bilker WB, Nachamkin I, et al.: Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with\u00a0Escherichia coli with reduced fluoroquinolone susceptibility. Infect Control Hosp Epidemiol 2013; 34: 1070\u20136","DOI":"10.1086\/673155"},{"key":"10.3238\/arztebl.2016.0454_ref31","doi-asserted-by":"crossref","unstructured":"Vibet MA, Roux J, Montassier E, et al.: Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis. Eur J Clin Microbiol Infect Dis 2015; 34: 1957\u201363","DOI":"10.1007\/s10096-015-2437-3"},{"key":"10.3238\/arztebl.2016.0454_ref32","doi-asserted-by":"crossref","unstructured":"Gefenaite G, Bijlsma MJ, Bos HJ, et al.: Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data. Euro Surveill 2014; 19: 20948","DOI":"10.2807\/1560-7917.ES2014.19.44.20948"},{"key":"10.3238\/arztebl.2016.0454_ref33","doi-asserted-by":"crossref","unstructured":"R\u00fcckinger S, van der Linden M, Reinert RR, et al: Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009; 27: 4136\u201341","DOI":"10.1016\/j.vaccine.2009.04.057"},{"key":"10.3238\/arztebl.2016.0454_ref34","doi-asserted-by":"crossref","unstructured":"Weiss S, Falkenhorst G, van der Linden M, et al.: Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012. Euro Surveill 2015; 20: 21057","DOI":"10.2807\/1560-7917.ES2015.20.10.21057"},{"key":"10.3238\/arztebl.2016.0454_ref35","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM): Brennen beim Wasserlassen. DEGAM-Leitlinie Nr. 1. Anwenderversion der S3-Leitlinie Harnwegsinfekt. omikron publishing D\u00fcsseldorf 2009. www.degam.de\/files\/Inhalte\/Leitlinien-Inhalte\/Dokumente\/DEGAM-S3-Leitlinien\/LL-01_Langfassung_mit_KV_ZD.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref36","doi-asserted-by":"crossref","unstructured":"Wagenlehner FME, Hoyme UB, Kaase M, et al.: Clinical Practice Guidelines: Uncomplicated urinary tract infections. Dtsch Arztebl Int 2011; 108: 415\u201323","DOI":"10.3238\/arztebl.2011.0415"},{"key":"10.3238\/arztebl.2016.0454_ref37","doi-asserted-by":"crossref","unstructured":"Petursson P: GPs\u2019 reasons for \u201enon-pharmacological\u201c prescribing of antibiotics. A phenomenological study. Scand J Prim Health Care 2005; 23: 120\u20135","DOI":"10.1080\/02813430510018491"},{"key":"10.3238\/arztebl.2016.0454_ref38","doi-asserted-by":"crossref","unstructured":"Cals JW, Boumans D, Lardinois RJ, et al.: Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br J Gen Pract 2007; 57: 942\u20137","DOI":"10.3399\/096016407782605027"},{"key":"10.3238\/arztebl.2016.0454_ref39","doi-asserted-by":"crossref","unstructured":"Briel M, Schuetz P, Mueller B, et al: Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168: 2000\u20137","DOI":"10.1001\/archinte.168.18.2000"},{"key":"10.3238\/arztebl.2016.0454_ref40","doi-asserted-by":"crossref","unstructured":"Stucker F, Herrmann F, Graf JD, et al.: Procalcitonin and infection in the elderly. J Am Geriatr Soc 2005; 53: 1392\u20135","DOI":"10.1111\/j.1532-5415.2005.53421.x"},{"key":"10.3238\/arztebl.2016.0454_ref41","unstructured":"Weltgesundheitsorganisation (WHO), Regionalb\u00fcro f\u00fcr Europa: Strategischer Aktionsplan zur Bek\u00e4mpfung von Antibiotikaresistenzen. Kopenhagen, 2011. www.euro.who.int\/__data\/assets\/pdf_file\/0010\/147736\/wd14G_AntibioticResistance_111382bhn.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref42","unstructured":"Zeidan R, Telschow C, Schr\u00f6der H: Antibiotikaverbrauch im ambulanten Bereich. In: Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit (BVL), Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e. V. (PEG), Infektiologie Freiburg (IF) (eds..): GERMAP 2012 Antibiotika-Resistenz und -Verbrauch. Antiinfectives Intelligence. Rheinbach 2014, pp. 9\u201317. www.bvl.bund.de\/SharedDocs\/Downloads\/05_Tierarzneimittel\/germap2012.pdf (last accessed on 11 April 2016)."},{"key":"10.3238\/arztebl.2016.0454_ref43","unstructured":"European Centre for Disease Prevention and Control (ECDC): Surveillance of antimicrobial consumption in Europe 2012. Stockholm, Sweden 2014. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/antimicrobial-consumption-europe-esac-net-2012.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref44","unstructured":"Hering R, Schulz M, B\u00e4tzing-Feigenbaum J: Entwicklung der ambulanten Antibiotikaverordnungen im Zeitraum 2008 bis 2012 im regionalen Vergleich. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland (Zi) \u2013 Versorgungsatlas. Berlin 2014. www.versorgungsatlas.de\/fileadmin\/ziva_docs\/50\/VA_50_2014_Antibiotika_imZeitverlauf_2008bis2012_Bericht.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref45","unstructured":"European Centre for Disease Prevention and Control (ECDC): Summary of the latest data on antibiotic resistance in the European Union. Stockholm, Sweden, 2014. http:\/\/ecdc.europa.eu\/en\/eaad\/Documents\/antibiotic-resistance-in-EU-summary.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref46","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (DIMDI): ATC-Klassifikation mit definierten Tagesdosen DDD. K\u00f6ln 2014. www.dimdi.de\/dynamic\/de\/klassi\/downloadcenter\/atcddd\/ (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref47","unstructured":"Wissenschaftliches Institut der AOK (WIdO): Amtlicher ATC-Index mit DDD-Angaben f\u00fcr das Jahr 2005\u20132014. Berlin 2014. www.wido.de\/amtl_atc-code.html (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref48","unstructured":"Bundesministerium f\u00fcr Gesundheit (BMG): Zahlen und Fakten zur Krankenversicherung \u2013 Mitglieder und Versicherte. Informationen rund um Mitglieder und Versicherte der GKV. Berlin. www.bmg.bund.de\/themen\/krankenversicherung\/zahlen-und-fakten-zur-krankenversicherung\/mitglieder-und-versicherte.html (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref49","unstructured":"National Cancer Institute: Joinpoint Trend Analysis Software (Version 4.2.0.2). Bethesda MA, USA 2015. http:\/\/surveillance.cancer.gov\/joinpoint\/ (last accessed 22 September 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref50","doi-asserted-by":"crossref","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al.: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335\u201351 (correction: 2001; 20: 655)","DOI":"10.1002\/sim.811"},{"key":"10.3238\/arztebl.2016.0454_ref51","unstructured":"Schulz M, Kern WV, Hering R, et al.: Antibiotikaverordnungen in der ambulanten Versorgung in Deutschland bei bestimmten Infektionserkrankungen. Teil 1 \u2013 Hintergrund, Methode und Hauptergebnisse einer Analyse von Qualit\u00e4tsindikatoren. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland (Zi) \u2013 Versorgungsatlas. Berlin 2014. www.versorgungsatlas.de\/fileadmin\/ziva_docs\/46\/Antibiotika_best_Infektionskrankheiten_Hauptbericht.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref52","unstructured":"Schulz M, Kern WV, Hering R, et al.: Antibiotikaverordnungen in der ambulanten Versorgung in Deutschland bei bestimmten Infektionserkrankungen. Teil 2 \u2013 Krankheitsspezifische Analyse von Qualit\u00e4tsindikatoren auf regionaler Ebene. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland (Zi) \u2013 Versorgungsatlas. Berlin 2014. www.versorgungsatlas.de\/fileadmin\/ziva_docs\/46\/Antibiotika_best_Infektionskrankheiten_Nebenbericht.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref53","unstructured":"Kern WV, Nink K: Antibiotikaverbrauch im ambulanten Bereich. In: Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit (BVL), Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e. V. (PEG), Infektiologie Freiburg (IF) (eds..): GERMAP 2010 Antibiotika-Resistenz und -Verbrauch. Antiinfectives Intelligence, Rheinbach 2011, pp. 11\u201316. www.bvl.bund.de\/SharedDocs\/Downloads\/08_PresseInfothek\/Germap_2010.pdf (last accessed on 11 April 2016)."},{"key":"10.3238\/arztebl.2016.0454_ref54","unstructured":"Robert Koch-Institut (RKI): SurvStat@RKI 2.0. https:\/\/survstat.rki.de (last accessed on 15 April 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref55","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (AKd\u00c4): Empfehlungen zur Therapie akuter Atemwegsinfektionen und der ambulant erworbenen Pneumonie (3. edition). Arzneiverordnung in der Praxis, Band 40; Sonderheft 1 (Therapieempfehlungen). Berlin 2013. www.akdae.de\/Arzneimitteltherapie\/TE\/A-Z\/PDF\/Atemwegsinfektionen.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref56","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM): Husten \u2013 DEGAM-Leitlinie Nr. 11 (Stand Juni 2008). omikron publishing, D\u00fcsseldorf 2008. www.degam.de\/files\/Inhalte\/Leitlinien-Inhalte\/Dokumente\/DEGAM-S3-Leitlinien\/LL-11_Langfassung_TJ_03_ZD_01.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref57","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM): Husten \u2013 DEGAM-Leitlinie Nr. 11 (Stand Februar 2014). Frankfurt a. M. 2014. www.degam.de\/files\/Inhalte\/Leitlinien-Inhalte\/Dokumente\/DEGAM-S3-LeitlinienLangfassung_Leitlinie_Husten_20140320.pdf (last accessed on 28 July 2015)"},{"key":"10.3238\/arztebl.2016.0454_ref58","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM): Rhinosinusitis \u2013 DEGAM-Leitlinie Nr. 10 (Stand Juni 2008). omikron publishing, D\u00fcsseldorf, 2008. www.degam.de\/files\/Inhalte\/Leitlinien-Inhalte\/Dokumente\/DEGAM-S3-Leitlinien\/LL-10_Langfassung_Rhinosinusitis-005B.pdf (last accessed on 28 July 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref59","doi-asserted-by":"crossref","unstructured":"Heppner HJ, Bertsch T, Alber B, et al.: Procalcitonin: inflammatory biomarker for assessing the severity of CAP: a clinical observation in geriatric patients. Gerontology 2010; 56: 385\u20139","DOI":"10.1159\/000262285"},{"key":"10.3238\/arztebl.2016.0454_ref60","doi-asserted-by":"crossref","unstructured":"Adriaenssens N, Coenen S, Versporten A, et al.; ESAC Project Group: European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011; 66 (Suppl 6): 71\u20137.","DOI":"10.1093\/jac\/dkr459"},{"key":"10.3238\/arztebl.2016.0454_ref61","doi-asserted-by":"crossref","unstructured":"Drekonja DM, Filice GA, Greer N, et al.: Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015; 36: 142\u201352","DOI":"10.1017\/ice.2014.41"},{"key":"10.3238\/arztebl.2016.0454_ref62","unstructured":"Robert Koch-Institut (RKI): Antibiotikaverbrauchs-Surveillance. https:\/\/avs.rki.de\/Content\/Preface\/Surveillance.aspx (last accessed 23 December 2015)."},{"key":"10.3238\/arztebl.2016.0454_ref63","unstructured":"Sundmacher L, Ozegowski S. Bedarfsplanung \u2013 Ziehen Privatpatienten \u00c4rzte an? Gesundheit und Gesellschaft 2013; 16: 32\u20136."},{"key":"10.3238\/arztebl.2016.0454_ref64","doi-asserted-by":"crossref","unstructured":"Halling F: Antibiotika in der Zahnmedizin. Zahnmedizin up2date 2014; 8: 67\u201382","DOI":"10.1055\/s-0033-1346918"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:39:53Z","timestamp":1638797993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":64,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0454","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}